Clinical trial
Phase III Study of Individualized Adaptive Radiotherapy Based on PET/CT and 3DCRT/IMRT in Combination With Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT02790190 is registered in ClinicalTrials.gov with Shandong Cancer Hospital and Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Study of Individualized Adaptive Radiotherapy Based on PET/CT and 3DCRT/IMRT in Combination With Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Lead sponsor
- Shandong Cancer Hospital and Institute
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 31, 2015
- Completion date
- December 31, 2017
- Enrollment
- 400 (estimated)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.